HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis Omeprazole Offering, Wellpoint, Prilosec OTC Pressure PPI Prices

This article was originally published in The Tan Sheet

Executive Summary

Novartis' entrance into the OTC loratadine market in March could set a precedent for the firm to make a similar move with the proton pump inhibitor omeprazole

You may also be interested in...



Wellpoint Prilosec program

Wellpoint expands availability of its discount program for the OTC proton pump inhibitor into Virginia in August with "other geographies to follow," the insurer says during second quarter earnings call. The initiative "allows members, with a doctor's consent, to access a 90-day supply of Prilosec OTC for $16, considerably less than their prescription drug co-payment." Wellpoint launched the coupon plan in California and Georgia in 2003 (1"The Tan Sheet" Aug. 25, 2003, p. 6). The provider has advocated Rx-to-OTC switches in certain categories to lower healthcare costs...

Blue Cross Michigan backs Prilosec OTC

Coupons offering $5 off the price of Prilosec OTC are now being mailed to 12,000 health plan members who could benefit from a discount on heartburn medication, Blue Cross Blue Shield of Michigan announces March 18. The cost of the coupon - which expires May 31, 2004 - is covered by the manufacturer, according to BCBSM. Similar discount programs supporting OTC use of Prilosec were undertaken in Fall 2003 by Blue Cross Blue Shield of Georgia and California (1"The Tan Sheet" Oct. 27, 2003, In Brief and 2"The Tan Sheet" Aug. 25, 2003, p. 6)...

Prilosec OTC Formulation Targeted In Mylan Labs Suit

Mylan Laboratories' lawsuit against Procter & Gamble over the formulation of Prilosec OTC is the most recent in a string of challenges for the over-the-counter heartburn medication

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS129780

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel